The community for India's most competitive biopharmaceutical companies.

Over the past few years, the IndiaBio Hotbed has made a name for itself in increasingly competitive biopharmaceutical niches. Specifically, India has become a leader in vaccine development and bioinformatics among others. India is also a global leader in contract research and development and manufacturing. IndiaBio is emerging as one of the strongest biopharmaceutical markets in Asia and is expected to continue growing and developing.

Sponsor
Pfizer


Hotbed News
Nine Ways to Avoid Investing in Biotech Duds Friday, February 27, 2015
Wearable Technology Is Redefining What It Means To Be Disabled Tuesday, February 10, 2015
Massive 91% of Poll Respondents Believe Big Pharma Will Continue Job Cuts in 2015 Friday, February 27, 2015
Amneal, Pfizer (PFE), Novartis AG (NVS) Eye Takeover of CLARIS Lifesciences's Injectables Biz Wednesday, February 18, 2015
Day in the Life of a CEO—Jim Bianco, CTI BioPharma Thursday, February 05, 2015
BoneSupport Receives Approval To Market CERAMENT In India Wednesday, February 25, 2015
EXCLUSIVE: Evercore ISI Breaks Down Valeant (VRX) / Salix (SLXP) Deal By the Numbers Monday, February 23, 2015
BioSpace (DHX) Poll Correctly Predicted New Sanofi (SAN.PA) CEO, Even Naming Correct Candidate Monday, February 23, 2015
Snag a Job: Here's How CSL Behring Makes Hiring Decisions Friday, February 13, 2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) Thursday, January 29, 2015
12345678910